Trial Profile
A Randomized Controlled Trial of Two Hepatitis A Vaccine Doses Among Adolescents With Juvenile Idiopathic Arthritis and Crohn's Disease on Immunosuppressive Therapy: A Pilot Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2023
Price :
$35
*
At a glance
- Drugs Hepatitis A vaccine inactivated (Primary)
- Indications Hepatitis A
- Focus Pharmacodynamics
- 10 Jul 2023 Status changed from recruiting to completed.
- 02 Oct 2021 Planned End Date changed from 1 Dec 2020 to 1 Dec 2022.
- 02 Oct 2021 Planned primary completion date changed from 1 Dec 2020 to 1 Dec 2022.